跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
力百汀 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Amoxicillin Sodium and Clavulanate Potassium for Injection
Approved
化学药品
Amoxicillin Sodium and Clavulanate Potassium for Injection
BEECHAM GROUP P L C
🇨🇳 National Medical Products Administration
Approval Date
May 28, 2018
Approval ID
7MazXbORypr
Company
BEECHAM GROUP P L C
Type
化学药品
Approval Details
Approval Id
7MazXbORypr
Approval Number
H20130420
Generic Name
注射用阿莫西林钠克拉维酸钾
Generic Name En
Amoxicillin Sodium and Clavulanate Potassium for Injection
Trade Name
力百汀
Drug Type
化学药品
Dosage Form
注射剂
Strength
1.2g(5:1)
Reg Date
2018-05-28
Expired Date
2023-05-27
Company Name
BEECHAM GROUP P L C
Company Address
980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom
Production Company Name
SMITHKLINE BEECHAM PHARMACEUTICALS
Production Company Address
Clarendon Road, Worthing, West Sussex, BN14 8QH,United Kingdom
Company Detail Path
/organization/beecham-group-p-l-c
Production Company Detail Path
/organization/smithkline-beecham-pharmaceuticals
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
May 28, 2018
Approval ID
7MazXbORypr
Type
化学药品
Back to NMPA Approvals